代谢功能障碍相关脂肪性肝病比脂肪肝或非酒精性脂肪性肝病更能预测慢性肾脏病新发
多变量Cox分析显示,仅MAFLD是新发CKD的独立危险因素(HR 1.12,95%CI 1.02-1.26;P=0.027),且将MAFLD加入传统危险因素后对CKD的判别能力改善优于加入脂肪肝或NAFLD。
要点
- MAFLD是新发CKD的独立危险因素(HR 1.12,95%CI 1.02-1.26;P=0.027)。
- 脂肪肝和NAFLD均不是新发CKD的独立危险因素。
- MAFLD对CKD风险的预测能力优于脂肪肝或NAFLD。
核心结论
- MAFLD与新发CKD呈适度且独立的关联,且预测CKD发生风险的能力优于脂肪肝或NAFLD。
研究设计与样本
- CKD定义为估算肾小球滤过率(eGFR)<60 mL/min/1.73 m2或尿蛋白阳性。
主要发现
- 脂肪肝、NAFLD和MAFLD的患病率分别为34.6%(男45.1%,女15.1%)、32.8%(男42.7%,女14.5%)和32.3%(男42.4%,女13.4%)。
- 10年随访期间,2163名受试者(男1475,女688)新发CKD。
- 多变量Cox比例风险模型分析显示,调整年龄、性别、eGFR、当前吸烟习惯、缺血性心脏病、糖尿病、超重/肥胖、高血压和血脂异常后,MAFLD是新发CKD的独立危险因素(HR 1.12,95%CI 1.02-1.26;P=0.027),而脂肪肝或NAFLD不是。
- 将MAFLD加入不含代谢异常的传统危险因素后,连续净重分类改善(NRI)为0.154,综合判别改善(IDI)为0.0024,其判别能力改善优于加入脂肪肝(NRI 0.138,IDI 0.0018)或NAFLD(NRI 0.132,IDI 0.0017)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Possible associations of chronic kidney disease (CKD) with fatty liver (FL) and nonalcoholic fatty liver disease (NAFLD) have recently been focused on. Metabolic dysfunction-associated fatty liver disease (MAFLD), defined as FL with overweight/obesity, type 2 diabetes mellitus or metabolic abnormalities, has been proposed as a new feature of chronic liver disease. However, the relationship between MAFLD and new onset of CKD has not been fully addressed. METHODS: We investigated the associations of FL, NAFLD and MAFLD with the development of CKD, defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2 or positive for urinary protein, over a 10-year period in 28 890 Japanese subjects who received annual health examinations. After exclusion of subjects with no data for abdominal ultrasonography and subjects with CKD at baseline, a total of 13 159 subjects (men 8581, women 4578; mean age 48 years) were recruited. RESULTS: The prevalence of FL, NAFLD and MAFLD was 34.6% (men 45.1%, women 15.1%), 32.8% (men 42.7%, women 14.5%) and 32.3% (men 42.4%, women 13.4%), respectively. During the 10-year follow-up period, 2163 subjects (men 1475, women 688) had new onset of CKD. Multivariable Cox proportional hazards model analyses showed that MAFLD [hazard ratio 1.12 (95% confidence interval 1.02-1.26); P = .027] but not FL or NAFLD was an independent risk factor for new onset of CKD after adjustment of age, sex, eGFR, current smoking habit, ischemic heart disease, diabetes mellitus, overweight/obesity, hypertension and dyslipidemia. The addition of MAFLD [continuous net reclassification improvement (NRI) 0.154, integrated discrimination improvement (IDI) 0.0024] to traditional risk factors without metabolic abnormalities significantly improved the discriminatory capacity better than did the addition of FL (NRI 0.138, IDI 0.0018) or NAFLD (NRI 0.132, IDI 0.0017). CONCLUSIONS: MAFLD is modestly and independently associated with new onset of CKD and predicts the risk for development of CKD better than FL or NAFLD.
引用
- Tanaka M, Mori K, Takahashi S, et al. Metabolic dysfunction-associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease. Nephrol Dial Transplant. 2023. PMID: 35612975. doi:10.1093/ndt/gfac188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。